B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset

Neuroscience Letters

Volumn 487, Issue 3, 2011, Pages 273-277

  Lee Chang, Catalina ^a,b   Zéphir, Hélène ^a,b   Top, Isabelle ^a,b   Dubucquoi, Sylvain ^a,b   Trauet, Jacques ^a,b   Prin, Lionel ^a,b   Vermersch, Patrick ^a,b  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Adhesion molecules; B cell subsets; Cerebrospinal fluid; Clinically isolated syndrome

Indexed keywords

ALPHA4 INTEGRIN; CD19 ANTIGEN; CELL ADHESION MOLECULE; GADOLINIUM;

ADULT; ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; CELL SUBPOPULATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICALLY ISOLATED SYNDROME; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATION; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; MEMORY CELL; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNDROME; UPREGULATION;

EID: 78650523883     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.036     Document Type: Article

References (28)

1. Bussone G., Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun. Rev. 2009, 8:332-336.
2. Comi G., Martinelli V., Rodegher M., Moiola L., Bajenaru O., Carra A., Elovaara I., Fazekas F., Hartung H.P., Hillert J., King J., Komoly S., Lubetzki C., Montalban X., Myhr K.M., Ravnborg M., Rieckmann P., Wynn D., Young C., Filippi M., PreCISe study group Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 2009, 374:1503-1511.
3. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., Gambini C., Mancardi G.L., Uccelli A., Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11064-11069.
4. + T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004, 103:4222-4231.
5. Durelli L., Conti L., Clerico M., Boselli D., Contessa G., Ripellino P., Ferrero B., Eid P., Novelli F. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann. Neurol. 2009, 65:499-509.
6. Eikelenboom M.J., Killestein J., Izeboud T., Kalkers N.F., Baars P.A., van Lier R.A., Barkhof F., Uitdehaag B.M., Polman C.H. Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS. J. Neuroimmunol. 2005, 158:222-230.
7. Endres R., Alimzhanov M.B., Plitz T., Fütterer A., Kosco-Vilbois M.H., Nedospasov S.A., Rajewsky K., Pfeffer K. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J. Exp. Med. 1999, 189:159-168.
8. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 1999, 5:170-175.
9. Harp C.T., Lovett-Racke A.E., Racke M.K., Frohman E.M., Monson N.L. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Clin. Immunol. 2008, 128:382-391.
10. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., Johnson L.L., Swain S.L., Lund F.E. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 2000, 1:475-482.
11. Jacobs L.D., Beck R.W., Simon J.H., Kinkel R.P., Brownscheidle C.M., Murray T.J., Simonian N.A., Slasor P.J., Sandrock A.W. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N. Engl. J. Med. 2000, 343:898-904.
12. Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., Duquette P., Prat A. Preferential recruitment of interferon-gamma-expressing T H 17 cells in multiple sclerosis. Ann. Neurol. 2009, 66:390-402.
13. Khoury S.J., Orav E.J., Guttmann C.R., Kikinis R., Jolesz F.A., Weiner H.L. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis. Neurology 1999, 53:758-764.
14. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisäkk P., Ransohoff R.M., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
15. Kuenz B., Lutterotti A., Ehling R., Gneiss C., Haemmerle M., Rainer C., Deisenhammer F., Schocke M., Berger T., Reindl M. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 2008, 3:e2559.
16. Lefranc D., Almeras L., Dubucquoi S., de Seze J., Vermersch P., Prin L. Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool. J. Immunol. 2004, 172:669-678.
17. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
18. McLean B.N., Luxton R.W., Thompson E.J. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain 1990, 113(Pt 5):1269-1289.
19. Miller D.H., Grossman R.I., Reingold S.C., McFarland H.F. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998, 121(Pt 1):3-24.
20. Naismith R.T., Piccio L., Lyons J.A., Lauber J., Tutlam N.T., Parks B.J., Trinkaus K., Song S.K., Cross A.H. Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology 2010, 74:1860-1867.
21. Niino M., Hirotani M., Miyazaki Y., Sasaki H. Memory and naïve B-cell subsets in patients with multiple sclerosis. Neurosci. Lett. 2009, 464:74-78.
22. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
23. Owens G.P., Ritchie A.M., Burgoon M.P., Williamson R.A., Corboy J.R., Gilden D.H. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 2003, 171:2725-2733.
24. Sellebjerg F., Börnsen L., Khademi M., Krakauer M., Olsson T., Frederiksen J.L., Sørensen P.S. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 2009, 73:2003-2010.
25. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
26. Villar L.M., Masjuan J., González-Porqué P., Plaza J., Sádaba M.C., Roldán E., Bootello A., Alvarez-Cermeño J.C. Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS. Neurology 2002, 58:824-826.
27. Weller S., Faili A., Garcia C., Braun M.C., Le Deist F., de Saint Basile G., Hermine O., Fischer A., Reynaud C.A., Weill J.C. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:1166-1170.
28. Zéphir H., Lefranc D., Dubucquoi S., de Seze J., Boron L., Prin L., Vermersch P. Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis. Mult. Scler. 2009, 15:593-600.